Drug Pricing

New Disclosure Law Shines Light on Prescribing Practices

New Disclosure Law Shines Light on Prescribing Practices
Share

By Jordan Paradise This week, the New York Times reported that ophthalmologists who were paid to promote Genentech’s drug Lucentis (ranibizumab) were among the top billers of the drug to federal programs, exceeding the prescribing amounts of more than 75% of their peers.  Lucentis, approved in 2006 by the Food and Drug Administration (FDA), is indicated […]

Share

Continue Reading »

We’re Back!

We’re Back!
Share

Here at Seton Hall Law, the halls are filled with the sounds of students again, which means our summer-long blog hiatus has come to an end.  We’re excited to get back to blogging at Health Reform Watch! As always, the blog will feature analysis and commentary from Seton Hall’s health law faculty and Recommended Reading […]

Share

Continue Reading »

Why Reduce Health Care Costs?

Why Reduce Health Care Costs?
Share

One rare point of elite consensus is that the US needs to reduce health care costs. Frightening graphs expose America as a spendthrift outlier. Before he decamped to Citigroup, the President’s OMB director warned about how important it was to “bend the cost curve.” The President’s opponents are even more passionate about austerity. Journalists and […]

Share

Continue Reading »

Discount Prescription Program Available To Some Locals

Filed in Drug Pricing by on April 20, 2011 0 Comments
Discount Prescription Program Available To Some Locals
Share

Listen up, Hoboken, Newark, and Orange residents.  There’s a new prescription discount program in town: Coast2Coast Rx Card.  Well, the program isn’t all that new to the area: Newark launched it last year and Hoboken launched it in January.  However, I didn’t learn about Coast2Coast Rx Card until I filled a prescription at my local […]

Share

Continue Reading »

Antibiotic Resistance on the Rise, Thanks to Capital Misallocation on a Grand Scale

Filed in Bioethics, Drug Pricing, Drugs & Devices by on April 7, 2011 0 Comments
Antibiotic Resistance on the Rise, Thanks to Capital Misallocation on a Grand Scale
Share

As Kevin Outterson & Aaron Kesselheim have been arguing for years, antibiotic resistance is a huge and growing problem. The Guardian’s Frank Swain offers an international perspective: An unusually hardy strain of Klebsiella pneumoniae was isolated from a 59-year-old Swedish patient who had been treated in a New Delhi hospital. The bacterium was found to be indifferent […]

Share

Continue Reading »